Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...

CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

Ahmedabad: The proportion of head and neck cancer patients under age 50 has gone up from 36.5% to 47.4% over the past two ...

In an interview with HT lifestyle, Dr. Vishal Bansal, senior consultant - surgical oncology, Fortis Hospital, Noida said, “The risk of head and neck cancer in tobacco users is approximately 10 times ...

Adjuvant Opdivo, cisplatin and radiotherapy improved DFS vs other treatment among those with locally advanced squamous cell ...

Alarmingly, head and neck cancer ranks second most common in India, heavily linked to tobacco use, especially smoking.

After Bicara reported a 12-month OS of 61% for its HPV-negative population last week, biotech Merus shared that its ...

A major trial found found that those who received the immunotherapy drug, pembrolizumab, alongside surgery and radiotherapy ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...